Life ScienceCompany
Where is Agios - Oncology Business headquartered?
Agios - Oncology Business is headquartered in Cambridge, Massachusetts.
What sector is Agios - Oncology Business in?
Agios - Oncology Business is a life science company.
Agios - Oncology Business is headquartered in Cambridge, Massachusetts.
Agios - Oncology Business is a life science company.
Cambridge, Massachusetts
02139
United States,
Agios' Oncology Business is a developer of TIBSOVO® which is approved in the U.S. as monotherapy for the treatment of adults with IDH1-mutant relapsed or refractory acute myeloid leukemia (AML) and for adults with newly diagnosed IDH1-mutant AML who are ≥75 years old or who have comorbidities that preclude the use of intensive induction chemotherapy. Agios’ oncology pipeline and clinical programs, including vorasidenib, an investigational, brain-penetrant, dual inhibitor of mutant IDH1 and IDH2 which is currently being studied in the registration-enabling Phase 3 INDIGO study in patients with IDH-mutant low-grade glioma Agios' Oncology Business is based in Cambridge, Massachusetts.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
